Cellcolabs Raises $8.7M to Make Stem Cells Cheaper for Novel Treatment Research

Cellcolabs has raised $8.7m from angel investors to expand production facilities and grow employee headcount. The Sweden-based company manufactures specialised stem cells that can be used to develop cell therapy treatments for diseases associated with inflammation.